LPHeader-2

Webinar: "Next generation proteomics for oncology research: A Mass Spectrometry complementary approach"

Please join us on the 7th June 2022, from 10:00 – 11:30 CEST to learn about Olink’s PEA technology for human proteomic analysis, listen to a case study on oncology and hear from Dr Stefan Enroth from Uppsala University, Sweden about “High-precision biomarkers for Ovarian Cancer: Experiences with Olink Explore”.

What you will learn from this webinar:    

  • Introduction to Proximity Extension Assay (PEA) technology for human proteomic analysis
  • Complement Mass Spectrometry based proteomic analysis to identify common and distinctive biomarkers for cancer immunotherapy
  • Proteomic approaches in plasma and serum samples to identify common and distinctive biomarkers
  • Identify high-precision biomarkers for Ovarian Cancer using Olink Explore

Speakers

stefanenroth
Dr Stefan Enroth
 

Swedish Collegium for Advanced Study, Uppsala.

Department of Immunology, Genetics and Pathology, Uppsala University, Sweden
marijana
Marijana Rucevic
 
Scientific Director
Olink
tuula
Tuula Nyman
 
Head of the Proteomics Core Facility, NAPI project manager
Oslo University Hospital
 
Sandra

Sandra Kyrk

Business Development Manager

Olink

About Us

Olink’s mission is to accelerate proteomics together with the scientific community, to understand real-time biology and gain actionable insights into human health and disease. Our innovative solutions deliver highly sensitive and accurate protein quantification, giving scientists the power to investigate complex biological processes with precision.

Learn more

    Contact Us

    +46 18 444 39 70
    Olink Proteomics AB
    Salagatan 16F
    SE-753 30 Uppsala
    Sweden